|
|
Volumn 12 Suppl 1, Issue , 2013, Pages
|
|
Pitavastatin in cardiometabolic disease: therapeutic profile.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
PITAVASTATIN;
QUINOLINE DERIVATIVE;
BLOOD;
CARDIOVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
DRUG INTERACTION;
DYSLIPIDEMIA;
HUMAN;
METABOLIC SYNDROME X;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT SELECTION;
REVIEW;
RISK FACTOR;
TREATMENT OUTCOME;
BIOLOGICAL MARKERS;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
DRUG INTERACTIONS;
DYSLIPIDEMIAS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPIDS;
METABOLIC SYNDROME X;
PATIENT SELECTION;
QUINOLINES;
RISK FACTORS;
TREATMENT OUTCOME;
|
|
EID: 84885946375
PISSN: None
EISSN: 14752840
Source Type: None
DOI: 10.1186/1475-2840-12-S1-S2 Document Type: Review |
|
Times cited : (22)
|
|
References (0)
|
